CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $576,300 | -83.4% | 15,000 | -90.0% | 0.01% | -81.1% |
| Q1 2023 | $3,463,240 | -11.6% | 149,600 | 0.0% | 0.05% | +10.4% |
| Q4 2022 | $3,919,520 | +33.3% | 149,600 | 0.0% | 0.05% | +37.1% |
| Q3 2022 | $2,941,000 | -46.9% | 149,600 | -52.7% | 0.04% | -45.3% |
| Q2 2022 | $5,538,000 | +85.7% | 316,611 | +73.7% | 0.06% | +100.0% |
| Q1 2022 | $2,982,000 | +0.3% | 182,300 | 0.0% | 0.03% | 0.0% |
| Q4 2021 | $2,973,000 | – | 182,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |